US Patent 11160754 Methods for treating lung disorders
Patent 11160754 was granted and assigned to CritiTech on November, 2021 by the United States Patent and Trademark Office.
All edits
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+225 characters)
Article
Patent abstract
Disclosed herein are compositions and methods for treating lung disorders including lung tumors by pulmonary administration of compositions comprising taxane particles such as docetaxel or paclitaxel particles.
Edits on 10 Oct, 2023
Golden AI
Edits made to:
Infobox (+5 properties)
Infobox
Patent Inventor Names
Gere S. diZerega0
James Verco0
Matthew McClorey0
Michael Baltezor0
William Johnston0
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 24 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
111607540
Date of Patent
November 2, 2021
0Patent Application Number
201910310
Date Filed
October 31, 2019
0Official Website
Edits on 19 May, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 9 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 11160754 Methods for treating lung disorders
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11160754
Date of patent
November 2, 2021
Patent application number
20191031
Date Filed
October 31, 2019
Find more entities like US Patent 11160754 Methods for treating lung disorders
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.